產(chǎn)品名稱：活體疫苗電穿孔系統(tǒng)
- 產(chǎn)品型號(hào)：Agile Pulse In Vivo
- 產(chǎn)品廠商：BTX
- 產(chǎn)品文檔：
AgilePulse InVivo彩頁
BTX電轉(zhuǎn)染應(yīng)用風(fēng)向標(biāo)
Agile Pulse In Vivo系統(tǒng)能有效增強(qiáng)免役反應(yīng)并縮短免役接種程序，從而極大提高您的實(shí)驗(yàn)效率。
Agile Pulse In Vivo系統(tǒng)廣泛應(yīng)用于：
皮下DNA疫苗接種
肌肉DNA疫苗接種
肌肉DNA疫苗接種
Drug導(dǎo)入
特點(diǎn)：
方波
多重方波
電阻/電擊脈沖監(jiān)控
實(shí)驗(yàn)日志存儲(chǔ)
無限量自定義程序存貯
遠(yuǎn)程控制
電穿孔應(yīng)用：
真核細(xì)胞
活體（活體電極）
皮下接種（針形矩陣電極）
肌肉接種（針形矩陣電極）
技術(shù)參數(shù)：
用戶界面：觸摸屏
電壓：50 -
1000 v
脈沖時(shí)間：5 μs - 10 ms
脈沖間隔時(shí)間：20 μs - 1 s
數(shù)據(jù)輸出：USB盤
產(chǎn)品尺寸（長x 寬x高）：12.6 x 7.9 x 15.7 in
重量：25 lbs
工作溫度：10° - 40° C
輸入電壓：100 -
250 VAC
Bongard N, Lapuente D, Windmann S, Dittmer U, Tenbusch M, Bayer, W. Interference of Retroviral Envelope with Vaccine-Induced CD8+ T Cell Responses is Relieved by Co-Administration of Cytokine-Encoding Vectors. Retrovirology. 2017;14: 28.
Eyquem J, et al. Targeting a CAR to the TRAC Locus with CRISPR/Cas9 Enhances Tumour Rejection. Nature. 2017;543: 113-117.
Juillerat A, et al. An Oxygen Sensitive Self-Decision Making Engineered CAR T-Cell. Sci Rep. 2017 Jan 20;7: 39833.
Denies S, et al. Evaluation of a Xenogeneic Vascular Endothelial Growth Factor-2 vaccine in Two Preclinical Metastatic Tumor Models in Mice. Cancer Immunol Immunother. 2017 Dec;66(12): 1545-1555.
Juillerat A, et al. Design of Chimeric Antigen Receptors with Integrated Controllable Transient Functions. Sci Rep. 2016 Jan 11;6: 18950.
Peterson CW, et al. Long-Term Multi-Lineage Engraftment of Genome-Edited Hematopoietic Stem Cells after Autologous Transplantation in Nonhuman Primates. Blood. 2016 May 19;127(20): 2416-2426.
Hawksworth DJ, Ziemann R, Manoj S. Enhanced Immune Response Following DNA Immunization Through In Vivo Electroporation. Monoclon Antib IImmunodiagn Immunother. 2016 Jul 27;35(5): 239-244.
Juillerat A, et al. Design of chimeric antigen receptors with integrated controllable transient functions. Sci Rep. 2016 Jan 11;6: 18950.
Christopher W, et al, Long-term multilineage engraftment of autologous genome-edited hematopoietic stem cells in nonhuman primates. Blood. 2016;127: 2416-2426.
Wang L, et al. Evaluation of Candidate Vaccine Approaches for MERS-CoV. Nat Comm. 2015 Jul28;6:7 712.
Davtyan H, et al. BTX AgilePulse(TM) System is an Effective Electroporation Device for Intramuscular and Intradermal Delivery of DNA Vaccine. Curr Gene Ther. 2014;14(3): 190-199.
Daftarian MP, Vosoughi A, Lemmon V. Gene-Based Vaccination and Screening Methods to Develop Monoclonal Antibodies. Methods Mol Biol. 2014;1121: 337-346.
Johansson DX, Ljungberg K, Kakoulidou M, Liljestrom P. Intradermal Electroporation of Naked Replicon RNA Elicits Strong Immune Responses. PLoS One, 2012 Jan 4;7(1): e29732.
Lladser A, Ljungberg K, Tufvesson H, Tazzari M, Roos A, Quest FG, Kiessling R. Intradermal electroporation with a survivin DNA vaccine induces CTLs against a self-epitope, suppresses angiogenesis and confers long-term protection against mouse melanoma. Cancer Immunol Immunother. 2010 Jan;59(1): 81-92.
Lundberg K, Roos A-K, Pavlenko M, Wehrum D, Pisa P. A modified epitope identified for generation and monitoring of PSA-specific T cells in patients on early phases of PSA-based immunotherapeutic protocols. Vaccine. 2009 Mar 4;27(10): 1557-65.
Br?ve A, Halleng?rd D, Gudmundsdotter L, Stout R, Walters R, Wahren B, Hallermalm K. Late administration of plasmid DNA by intradermal electroporation efficiently boosts DNA-primed T and B cell responses to carcinoembryonic antigen. Vaccine. 2009 Jun 8;27(28): 3692-6.
Roos, A-K, Eriksson, F, Walters, D, Pisa, P, King, A. Optimization of skin electroporation in mice to increase tolerability of DNA vaccine delivery to patients. Molecular Therapy. 2009 Sep;17(9): 1637-42.
